David Bumcrot
CIK: 0002033326
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CAMP
Camp4 Therapeutics Corp
Officer
Discretionary Trading P&L
Holdings
About Bumcrot David
Bumcrot David (SEC CIK 0002033326) files insider reports with the SEC as Chief Scientific Officer of Camp4 Therapeutics Corp (CAMP).
Signal8 holds 2 ownership filings by Bumcrot David (1 Form 3, 1 Form 4), filed between Oct 10, 2024 and Apr 3, 2025. Those filings report 1 transaction, the latest on Apr 1, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Bumcrot David's filings is in CAMBRIDGE, MA.
Recent filings by Bumcrot David
- Apr 1, 2025: Grant or award of CAMP derivative securities (Form 4, code A).
Other insiders filing for Camp4 Therapeutics Corp (CAMP)
- Gold Kelly, Chief Financial Officer
- Schwab Andrew J., Director
- Tardiff Daniel, Chief Scientific Officer
- 5AM Partners VI, LLC, 10% Owner
- Young Richard A, Director
- Maricich Yuri, Chief Medical Officer